Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Source link
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Source link
© 2023 GODJ - NEWS CORP - news.godj.com.